Patent · US Active

High-affinity DMF5 T cell receptor (TCR) variants

US9717758B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 16, 2014
Grant dateAug 1, 2017
Priority date
Expiry dateNov 7, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K40/4272
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

High-affinity variants of the DMF5 TCR, and methods of use thereof for the treatment and imaging of cancer in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.